The bill, HB 63, amends existing laws to enhance the management of anaphylaxis in educational and recreational settings by allowing authorized entities, such as schools, camps, and day care facilities, to possess and administer both epinephrine auto-injectors and epinephrine nasal spray. Key insertions in the bill include the addition of "epinephrine nasal spray" alongside "epinephrine auto-injectors" throughout relevant statutes (RSA 170-E:59 - 170-E:62 and RSA 200:42 - 200:45), which was not previously permitted. The legislation establishes conditions for children with severe allergies to possess and self-administer these medications, requiring written approval from a physician and parent or guardian, as well as verification of the child's ability to use the medication safely. It also outlines the responsibilities of school and camp personnel, including mandatory training on recognizing severe allergic reactions and administering the medications.

Additionally, the bill mandates the New Hampshire Department of Education to develop guidelines for managing students with life-threatening allergies, which must be implemented by school districts by September 1, 2017. The bill provides legal immunity to school districts and personnel regarding the administration of epinephrine, as long as they comply with established guidelines. It expands the definition of "trained designee" to include those trained in administering both types of epinephrine in postsecondary institutions and allows these institutions to create policies for emergency administration when licensed medical professionals are unavailable. Overall, the legislation aims to improve safety and preparedness for children with life-threatening allergies while ensuring that authorized entities are equipped to respond effectively in emergencies.

Statutes affected:
Introduced: 170-E:59, 200-N:1, 200-N:2, 200-N:5, 200-N:7, 329:1-h
As Amended by the House: 170-E:59, 200-N:1, 200-N:2, 200-N:5, 200-N:7, 329:1-h, 318:42